72 related articles for article (PubMed ID: 31332726)
21. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R; Bottaro DP; Choueiri TK; Gibbs RA; Godwin AK; Haake S; Hakimi AA; Henske EP; Hsieh JJ; Ho TH; Kanchi RS; Krishnan B; Kwiatkowski DJ; Lui W; Merino MJ; Mills GB; Myers J; Nickerson ML; Reuter VE; Schmidt LS; Shelley CS; Shen H; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Vincent BG; Vocke CD; Wheeler DA; Yang L; Kim WY; Robertson AG; ; Spellman PT; Rathmell WK; Linehan WM
Cell Rep; 2018 Jun; 23(12):3698. PubMed ID: 29925010
[No Abstract] [Full Text] [Related]
22. Immunotherapy in renal cell carcinoma: latest evidence and clinical implications.
Santoni M; Massari F; Di Nunno V; Conti A; Cimadamore A; Scarpelli M; Montironi R; Cheng L; Battelli N; Lopez-Beltran A
Drugs Context; 2018; 7():212528. PubMed ID: 29899754
[TBL] [Abstract][Full Text] [Related]
23. Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types.
Budczies J; Denkert C; Győrffy B; Schirmacher P; Stenzinger A
BMC Med Genomics; 2017 Dec; 10(1):74. PubMed ID: 29212506
[TBL] [Abstract][Full Text] [Related]
24. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection.
El-Mokadem I; Lim A; Kidd T; Garret K; Pratt N; Batty D; Fleming S; Nabi G
BMC Cancer; 2016 Jul; 16():546. PubMed ID: 27465101
[TBL] [Abstract][Full Text] [Related]
26. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Moch H; Cubilla AL; Humphrey PA; Reuter VE; Ulbright TM
Eur Urol; 2016 Jul; 70(1):93-105. PubMed ID: 26935559
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
; Linehan WM; Spellman PT; Ricketts CJ; Creighton CJ; Fei SS; Davis C; Wheeler DA; Murray BA; Schmidt L; Vocke CD; Peto M; Al Mamun AA; Shinbrot E; Sethi A; Brooks S; Rathmell WK; Brooks AN; Hoadley KA; Robertson AG; Brooks D; Bowlby R; Sadeghi S; Shen H; Weisenberger DJ; Bootwalla M; Baylin SB; Laird PW; Cherniack AD; Saksena G; Haake S; Li J; Liang H; Lu Y; Mills GB; Akbani R; Leiserson MD; Raphael BJ; Anur P; Bottaro D; Albiges L; Barnabas N; Choueiri TK; Czerniak B; Godwin AK; Hakimi AA; Ho TH; Hsieh J; Ittmann M; Kim WY; Krishnan B; Merino MJ; Mills Shaw KR; Reuter VE; Reznik E; Shelley CS; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Tickoo S; Burnett K; Crain D; Gardner J; Lau K; Mallery D; Morris S; Paulauskis JD; Penny RJ; Shelton C; Shelton WT; Sherman M; Thompson E; Yena P; Avedon MT; Bowen J; Gastier-Foster JM; Gerken M; Leraas KM; Lichtenberg TM; Ramirez NC; Santos T; Wise L; Zmuda E; Demchok JA; Felau I; Hutter CM; Sheth M; Sofia HJ; Tarnuzzer R; Wang Z; Yang L; Zenklusen JC; Zhang J; Ayala B; Baboud J; Chudamani S; Liu J; Lolla L; Naresh R; Pihl T; Sun Q; Wan Y; Wu Y; Ally A; Balasundaram M; Balu S; Beroukhim R; Bodenheimer T; Buhay C; Butterfield YS; Carlsen R; Carter SL; Chao H; Chuah E; Clarke A; Covington KR; Dahdouli M; Dewal N; Dhalla N; Doddapaneni HV; Drummond JA; Gabriel SB; Gibbs RA; Guin R; Hale W; Hawes A; Hayes DN; Holt RA; Hoyle AP; Jefferys SR; Jones SJ; Jones CD; Kalra D; Kovar C; Lewis L; Li J; Ma Y; Marra MA; Mayo M; Meng S; Meyerson M; Mieczkowski PA; Moore RA; Morton D; Mose LE; Mungall AJ; Muzny D; Parker JS; Perou CM; Roach J; Schein JE; Schumacher SE; Shi Y; Simons JV; Sipahimalani P; Skelly T; Soloway MG; Sougnez C; Tam A; Tan D; Thiessen N; Veluvolu U; Wang M; Wilkerson MD; Wong T; Wu J; Xi L; Zhou J; Bedford J; Chen F; Fu Y; Gerstein M; Haussler D; Kasaian K; Lai P; Ling S; Radenbaugh A; Van Den Berg D; Weinstein JN; Zhu J; Albert M; Alexopoulou I; Andersen JJ; Auman JT; Bartlett J; Bastacky S; Bergsten J; Blute ML; Boice L; Bollag RJ; Boyd J; Castle E; Chen YB; Cheville JC; Curley E; Davies B; DeVolk A; Dhir R; Dike L; Eckman J; Engel J; Harr J; Hrebinko R; Huang M; Huelsenbeck-Dill L; Iacocca M; Jacobs B; Lobis M; Maranchie JK; McMeekin S; Myers J; Nelson J; Parfitt J; Parwani A; Petrelli N; Rabeno B; Roy S; Salner AL; Slaton J; Stanton M; Thompson RH; Thorne L; Tucker K; Weinberger PM; Winemiller C; Zach LA; Zuna R
N Engl J Med; 2016 Jan; 374(2):135-45. PubMed ID: 26536169
[TBL] [Abstract][Full Text] [Related]
28. Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma.
Massari F; Ciccarese C; Bria E; Porta C; La Russa F; Knuutila S; Artibani W; Porcaro AB; Bimbatti D; Modena A; Sava T; Tortora G; Cheng L; Eccher A; Cima L; Pedron S; Ghimenton C; Martignoni G; Brunelli M
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):39-43. PubMed ID: 26509904
[TBL] [Abstract][Full Text] [Related]
29. A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies.
Rini B; Goddard A; Knezevic D; Maddala T; Zhou M; Aydin H; Campbell S; Elson P; Koscielny S; Lopatin M; Svedman C; Martini JF; Williams JA; Verkarre V; Radulescu C; Neuzillet Y; Hemmerlé I; Timsit MO; Tsiatis AC; Bonham M; Lebret T; Mejean A; Escudier B
Lancet Oncol; 2015 Jun; 16(6):676-85. PubMed ID: 25979595
[TBL] [Abstract][Full Text] [Related]
30. The somatic genomic landscape of chromophobe renal cell carcinoma.
Davis CF; Ricketts CJ; Wang M; Yang L; Cherniack AD; Shen H; Buhay C; Kang H; Kim SC; Fahey CC; Hacker KE; Bhanot G; Gordenin DA; Chu A; Gunaratne PH; Biehl M; Seth S; Kaipparettu BA; Bristow CA; Donehower LA; Wallen EM; Smith AB; Tickoo SK; Tamboli P; Reuter V; Schmidt LS; Hsieh JJ; Choueiri TK; Hakimi AA; ; Chin L; Meyerson M; Kucherlapati R; Park WY; Robertson AG; Laird PW; Henske EP; Kwiatkowski DJ; Park PJ; Morgan M; Shuch B; Muzny D; Wheeler DA; Linehan WM; Gibbs RA; Rathmell WK; Creighton CJ
Cancer Cell; 2014 Sep; 26(3):319-330. PubMed ID: 25155756
[TBL] [Abstract][Full Text] [Related]
31. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
[TBL] [Abstract][Full Text] [Related]
32. Significance of chromosome 9p status in renal cell carcinoma: a systematic review and quality of the reported studies.
El-Mokadem I; Fitzpatrick J; Rai B; Cunningham J; Pratt N; Fleming S; Nabi G
Biomed Res Int; 2014; 2014():521380. PubMed ID: 24877109
[TBL] [Abstract][Full Text] [Related]
33. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.
de Oliveira D; Dall'Oglio MF; Reis ST; Zerati M; Souza IC; Leite KR; Srougi M
Urol Oncol; 2014 Jul; 32(5):601-6. PubMed ID: 24629495
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive molecular characterization of clear cell renal cell carcinoma.
Cancer Genome Atlas Research Network
Nature; 2013 Jul; 499(7456):43-9. PubMed ID: 23792563
[TBL] [Abstract][Full Text] [Related]
35. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.
Heng DY; Xie W; Regan MM; Harshman LC; Bjarnason GA; Vaishampayan UN; Mackenzie M; Wood L; Donskov F; Tan MH; Rha SY; Agarwal N; Kollmannsberger C; Rini BI; Choueiri TK
Lancet Oncol; 2013 Feb; 14(2):141-8. PubMed ID: 23312463
[TBL] [Abstract][Full Text] [Related]
36. Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma.
Sanjmyatav J; Junker K; Matthes S; Muehr M; Sava D; Sternal M; Wessendorf S; Kreuz M; Gajda M; Wunderlich H; Schwaenen C
J Urol; 2011 Nov; 186(5):2078-83. PubMed ID: 21944119
[TBL] [Abstract][Full Text] [Related]
37. D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta.
Li X; Tan X; Yu Y; Chen H; Chang W; Hou J; Xu D; Ma L; Cao G
Cancer; 2011 Sep; 117(18):4201-11. PubMed ID: 21387281
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of cytogenetic analysis in clear cell renal carcinoma: a study on 131 patients with long-term follow-up.
Antonelli A; Arrighi N; Tardanico R; Balzarini P; Zanotelli T; Corti S; Zani D; Cozzoli A; Cunico SC; Simeone C
Anticancer Res; 2010 Nov; 30(11):4705-9. PubMed ID: 21115928
[TBL] [Abstract][Full Text] [Related]
39. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
La Rochelle J; Klatte T; Dastane A; Rao N; Seligson D; Said J; Shuch B; Zomorodian N; Kabbinavar F; Belldegrun A; Pantuck AJ
Cancer; 2010 Oct; 116(20):4696-702. PubMed ID: 20629029
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.
Heng DY; Xie W; Regan MM; Warren MA; Golshayan AR; Sahi C; Eigl BJ; Ruether JD; Cheng T; North S; Venner P; Knox JJ; Chi KN; Kollmannsberger C; McDermott DF; Oh WK; Atkins MB; Bukowski RM; Rini BI; Choueiri TK
J Clin Oncol; 2009 Dec; 27(34):5794-9. PubMed ID: 19826129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
